妇科恶性肿瘤的分子生物学 - Suppr

Suppr

超能文献

Molecular biology of gynecologic malignancies.

作者信息

Hamilton T C, Johnson S W, Godwin A K

机构信息

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

出版信息

Cancer Treat Res. 1998;95:103-14. doi: 10.1007/978-1-4615-5447-9_2.

DOI:10.1007/978-1-4615-5447-9_2

PMID:9619281

Abstract

摘要

相似文献

Molecular biology of gynecologic malignancies.

Cancer Treat Res. 1998;95:103-14. doi: 10.1007/978-1-4615-5447-9_2.

The molecular genetics of gyn malignancies.

Oncology (Williston Park). 1994 Oct;8(10):63-70, 73; discussion 73, 78-82.

Oncogenes and onco-suppressor genes in female genital cancer.

Ann N Y Acad Sci. 1997 Jun 17;816:347-55. doi: 10.1111/j.1749-6632.1997.tb52160.x.

Molecular genetics of gynecologic cancer.

J Korean Med Sci. 1997 Oct;12(5):383-9. doi: 10.3346/jkms.1997.12.5.383.

[Gynecologic malignancies].

Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1762-70.

Molecular advances in gynecologic oncology.

Curr Opin Oncol. 1999 Sep;11(5):394-400. doi: 10.1097/00001622-199909000-00013.

Oncogenes in gynecologic malignancy.

Curr Opin Obstet Gynecol. 1992 Feb;4(1):75-80.

Expression of the ras oncogene in gynecologic tumors.

Am J Obstet Gynecol. 1989 Feb;160(2):344-52. doi: 10.1016/0002-9378(89)90440-7.

Oncogenes in gynecologic oncology.

Obstet Gynecol Surv. 1996 Dec;51(12):710-7. doi: 10.1097/00006254-199612000-00003.

Advances in the pathology of gynecologic cancer.

Cancer Treat Res. 1998;95:353-76. doi: 10.1007/978-1-4615-5447-9_12.

引用本文的文献

Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

J Gynecol Oncol. 2009 Mar;20(1):48-54. doi: 10.3802/jgo.2009.20.1.48. Epub 2009 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Molecular biology of gynecologic malignancies.

Cancer Treat Res. 1998;95:103-14. doi: 10.1007/978-1-4615-5447-9_2.

The molecular genetics of gyn malignancies.

Oncology (Williston Park). 1994 Oct;8(10):63-70, 73; discussion 73, 78-82.

Oncogenes and onco-suppressor genes in female genital cancer.

Ann N Y Acad Sci. 1997 Jun 17;816:347-55. doi: 10.1111/j.1749-6632.1997.tb52160.x.

Molecular genetics of gynecologic cancer.

J Korean Med Sci. 1997 Oct;12(5):383-9. doi: 10.3346/jkms.1997.12.5.383.

[Gynecologic malignancies].

Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1762-70.

Molecular advances in gynecologic oncology.

Curr Opin Oncol. 1999 Sep;11(5):394-400. doi: 10.1097/00001622-199909000-00013.

Oncogenes in gynecologic malignancy.

Curr Opin Obstet Gynecol. 1992 Feb;4(1):75-80.

Expression of the ras oncogene in gynecologic tumors.

Am J Obstet Gynecol. 1989 Feb;160(2):344-52. doi: 10.1016/0002-9378(89)90440-7.

Oncogenes in gynecologic oncology.

Obstet Gynecol Surv. 1996 Dec;51(12):710-7. doi: 10.1097/00006254-199612000-00003.

Advances in the pathology of gynecologic cancer.

Cancer Treat Res. 1998;95:353-76. doi: 10.1007/978-1-4615-5447-9_12.

引用本文的文献

Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

J Gynecol Oncol. 2009 Mar;20(1):48-54. doi: 10.3802/jgo.2009.20.1.48. Epub 2009 Mar 31.